These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34214870)

  • 1. Explaining the individual challenges of women affected by neuromyelitis optica and multiple sclerosis: A comparative content analysis Study.
    Shabany M; Ayoubi S; Naser Moghadasi A; Najafi M; Eskandarieh S
    Clin Neurol Neurosurg; 2021 Aug; 207():106789. PubMed ID: 34214870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysphagia in neuromyelitis optica spectrum disorder and multiple sclerosis: A comparison of frequency, severity, and effects on quality of life.
    Afsharzadeh M; Mirmosayyeb O; Vaheb S; Shaygannejad A; Maracy M; Shaygannejad V
    Mult Scler Relat Disord; 2024 Jul; 87():105640. PubMed ID: 38692153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sociodemographic and clinical characteristics of people with multiple sclerosis and neuro-myelitis optica spectrum disorder in a central northern region of Chile: A prevalence study.
    Henríquez K; Molt F; Gajardo J; Cortés B; Ramirez-Santana M
    Mult Scler Relat Disord; 2022 May; 61():103750. PubMed ID: 35339742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short report: assessment of coping strategies in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis.
    Barzegar M; Allahdadian S; Mirmosayyeb O; Azarbayejani R; Badihian S; Nehzat N; Daryanavardi S; Barzegar S; Shaygannejad V
    Psychol Health Med; 2022 Jul; 27(6):1234-1244. PubMed ID: 33300373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric clinical and epidemiological comparison of neuromyelitis optica spectrum disorder with multiple sclerosis from India.
    Gupta S; Rehani V; Acharya R; Purohit P; Anadure R; Ahmad F; Soni R; Gupta A; Hiremath R
    Mult Scler Relat Disord; 2021 Jan; 47():102616. PubMed ID: 33166808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of recurrence risk perception and coping strategies in patients with neuromyelitis optica spectrum disorder: A qualitative study.
    Liao H; Fan P; Ruan H; Qiu W; Zhang M; Li H
    Mult Scler Relat Disord; 2024 Apr; 84():105419. PubMed ID: 38364767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: The first report from Iran.
    Barzegar M; Badihian S; Mirmosayyeb O; Ashtari F; Jamadi M; Emami S; Jahani L; Safavi A; Shaygannejad V
    Mult Scler Relat Disord; 2018 May; 22():161-165. PubMed ID: 29775851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influences of pregnancy on neuromyelitis optica spectrum disorders and multiple sclerosis.
    Tong Y; Liu J; Yang T; Kang Y; Wang J; Zhao T; Cheng C; Fan Y
    Mult Scler Relat Disord; 2018 Oct; 25():61-65. PubMed ID: 30048918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosis.
    Ashtari F; Manouchehri N; Shaygannejad V; Barekatain M; Adibi I; Afshari-Safavi A; Ramezani N; Ghalamkari A; Barzegar M
    Mult Scler Relat Disord; 2023 Feb; 70():104492. PubMed ID: 36587484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand.
    Siritho S; Thavorncharoensap M; Chanatittarat C; Pasogpakdee P; Apiwattanakul M; Prayoonwiwat N; Chankrachang S; Riewpaiboon A; Chaikledkaew U
    Mult Scler Relat Disord; 2018 Aug; 24():151-156. PubMed ID: 30015079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study.
    Ashtari F; Ataei A; Kafieh R; Khodabandeh Z; Barzegar M; Raei M; Dehghani A; Mansurian M
    Mult Scler Relat Disord; 2021 Jan; 47():102625. PubMed ID: 33227631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: A comparison in different ethnic groups.
    Viswanathan S; Rose N; Arip M; Chai CH; Law WC; Sim R; Ong MC
    Mult Scler Relat Disord; 2018 Oct; 25():300-308. PubMed ID: 30172173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder.
    Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Aoki R; Kuwabara S
    Clin Exp Immunol; 2020 Nov; 202(2):239-248. PubMed ID: 32643149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.
    Fragomeni MO; Bichuetti DB; Oliveira EML
    Mult Scler Relat Disord; 2018 Oct; 25():138-142. PubMed ID: 30075406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nationwide epidemiological study on the prevalence of multiple sclerosis and neuromyelitis optica spectrum disorder with important multi-ethnic differences in Malaysia.
    Viswanathan S; Wah LM
    Mult Scler; 2019 Oct; 25(11):1452-1461. PubMed ID: 30113245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity in the multiple sclerosis and neuromyelitis optica spectrum disorders population: findings from an underserved, low income country, Zambia.
    Tremlett H; Chomba M; Mortel D; Braun S; Chishimba L; Mutete F; Mwendaweli N; Namangala C; Zimba S; Saylor D
    Mult Scler Relat Disord; 2024 Jan; 81():105365. PubMed ID: 38101225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pruritus in neuromyelitis optica spectrum disorders and multiple sclerosis.
    He M; Wu L; Huang D; Yau V; Yu S
    J Clin Neurosci; 2020 Sep; 79():108-112. PubMed ID: 33070876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
    Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
    Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.